Neurotoxicity of amyloid β-protein: synaptic and network dysfunction
- PMID: 22762015
- PMCID: PMC3385944
- DOI: 10.1101/cshperspect.a006338
Neurotoxicity of amyloid β-protein: synaptic and network dysfunction
Abstract
Evidence for an ever-expanding variety of molecular mediators of amyloid β-protein neurotoxicity (membrane lipids, receptor proteins, channel proteins, second messengers and related signaling cascades, cytoskeletal proteins, inflammatory mediators, etc.) has led to the notion that the binding of hydrophobic Aβ assemblies to cellular membranes triggers multiple effects affecting diverse pathways. It appears unlikely that there are only one or two cognate receptors for neurotoxic forms of Aβ and also that there are just one or two assembly forms of the peptide that induce neuronal dysfunction. Rather, various soluble (diffusible) oligomers of Aβ that may be in dynamic equilibrium with insoluble, fibrillar deposits (amyloid plaques) and that can bind to different components of neuronal and non-neuronal plasma membranes appear to induce complex patterns of synaptic dysfunction and network disorganization that underlie the intermittent but gradually progressive cognitive manifestations of the clinical disorder. Modern analyses of this problem utilize electrophysiology coupled with synaptic biochemistry and behavioral phenotyping of animal models to elucidate the affected circuits and assess the effects of potential therapeutic interventions.
Figures



Similar articles
-
An Unbalanced Synaptic Transmission: Cause or Consequence of the Amyloid Oligomers Neurotoxicity?Int J Mol Sci. 2021 Jun 1;22(11):5991. doi: 10.3390/ijms22115991. Int J Mol Sci. 2021. PMID: 34206089 Free PMC article. Review.
-
Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits.PLoS One. 2014 Nov 12;9(11):e111898. doi: 10.1371/journal.pone.0111898. eCollection 2014. PLoS One. 2014. PMID: 25390368 Free PMC article.
-
Alzheimer's disease-associated neurotoxic mechanisms and neuroprotective strategies.Curr Drug Targets CNS Neurol Disord. 2005 Aug;4(4):383-403. doi: 10.2174/1568007054546117. Curr Drug Targets CNS Neurol Disord. 2005. PMID: 16101556 Review.
-
Structure-function implications in Alzheimer's disease: effect of Abeta oligomers at central synapses.Curr Alzheimer Res. 2008 Jun;5(3):233-43. doi: 10.2174/156720508784533321. Curr Alzheimer Res. 2008. PMID: 18537540 Review.
-
Is Alzheimer's disease a result of presynaptic failure? Synaptic dysfunctions induced by oligomeric beta-amyloid.Rev Neurosci. 2009;20(1):1-12. doi: 10.1515/revneuro.2009.20.1.1. Rev Neurosci. 2009. PMID: 19526730 Review.
Cited by
-
Targeting innate immunity for neurodegenerative disorders of the central nervous system.J Neurochem. 2016 Sep;138(5):653-93. doi: 10.1111/jnc.13667. J Neurochem. 2016. PMID: 27248001 Free PMC article. Review.
-
Different effects of soluble and aggregated amyloid β42 on gene/protein expression and enzyme activity involved in insulin and APP pathways.J Neural Transm (Vienna). 2013 Jan;120(1):113-20. doi: 10.1007/s00702-012-0852-5. Epub 2012 Jul 11. J Neural Transm (Vienna). 2013. PMID: 22782687
-
Potential of Extracellular Vesicles in Neurodegenerative Diseases: Diagnostic and Therapeutic Indications.J Mol Neurosci. 2018 Oct;66(2):172-179. doi: 10.1007/s12031-018-1135-x. Epub 2018 Aug 23. J Mol Neurosci. 2018. PMID: 30140997 Review.
-
De novo designed protein inhibitors of amyloid aggregation and seeding.Proc Natl Acad Sci U S A. 2022 Aug 23;119(34):e2206240119. doi: 10.1073/pnas.2206240119. Epub 2022 Aug 15. Proc Natl Acad Sci U S A. 2022. PMID: 35969734 Free PMC article.
-
Variation in Group Composition Alters an Early-Stage Social Phenotype in hAPP-Transgenic J20 Mice.J Alzheimers Dis. 2023;93(1):211-224. doi: 10.3233/JAD-221126. J Alzheimers Dis. 2023. PMID: 36970900 Free PMC article.
References
-
- Abramov E, Dolev I, Fogel H, Ciccotosto GD, Ruff E, Slutsky I 2009. Amyloid-β as a positive endogenous regulator of release probability at hippocampal synapses. Nat Neurosci 12: 1567–1576 - PubMed
-
- Bitan G, Lomakin A, Teplow DB 2001. Amyloid β-protein oligomerization: Prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins. J Biol Chem 276: 35176–35184 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical